Watchlist

Watchlist
Aralez Pharmaceuticals Inc. (ARLZ)
Aralez Pharmaceuticals Inc. (ARLZ)
Your Daily Pharma Scoop: Right Time To Buy Regeneron, Eli Lilly Gives Guidance, Bluebird Announces Offering
Content Analysis of coverage: REGN Stocks in the news: LLY, SNY, BLUE Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar Trade Idea of the Day (for TPT subscribers only) Subscriber Questions & An…
Nasdaq Biotech Index: 54 to be added, 15 removed
Changes will become effective prior to the open next Monday. ETF: IBB More news on: iShares Nasdaq Biotechnology ETF, Arbutus Biopharma Corp, Aclaris Therapeutics, Healthcare stocks news, News on ETFs, Read more …
Aralez chief financial officer exits company
Aralez Pharmaceuticals (NASDAQ: ARLZ ) says its chief financial officer is exiting to pursue other opportunities. More news on: Aralez Pharmaceuticals Inc., Healthcare stocks news, Read more …
Aralez Announces Departure of Chief Financial Officer
MISSISSAUGA, Ontario , Nov. 30, 2017 /PRNewswire/ -- Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced that Scott J. Charles , Chief Financial Officer, is leaving the Company to pursue other opportunities, effective immedi…
Aralez Pharmaceuticals: Update On Q3 Earnings Release
As I anticipated in my recent October 30th article , Aralez (NASDAQ: ARLZ ) released strong Q3 results on November 9th announcing positive adjusted EBITDA for the first time (albeit only $0.4 million). Aralez also upwardly revised its 2017 guidance, provided a preliminary full-year outlook…
Aralez Pharmaceuticals Inc. 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by Aralez Pharmaceuticals Inc. in conjunction with their 2017 Q3 earnings Read more …
Planned equity offering roundup - healthcare
Recent SEC filings for planned equity offerings by healthcare firms: More news on: CHECKPOINT THERAPEUTICS, Citius Pharmaceuticals Inc., CRISPR Therapeutics, Healthcare stocks news, Read more …
Aralez Pharmaceuticals' (ARLZ) CEO Adrian Adams on Q3 2017 Results - Earnings Call Transcript
Aralez Pharmaceuticals Inc. (ARLZ) Q3 2017 Earnings Conference Call November 9, 2017 8:30 AM ET Executives Adrian Adams Chief Executive Officer Nichol Ochsner Executive Director of Investor Relations and Corporate Communications Scott Charles Chief Fina…
Premarket Gainers as of 9:05 am
OTIC +114% on Q3 result . More news on: Otonomy, magicJack VocalTec Communications Ltd., KBS Fashion Group Limited, Stocks on the move, Read more …
Aralez Q3 beat stokes shares, up 22% premarket
Aralez Pharmaceuticals (NASDAQ: ARLZ ) Q3 results ($M): Revenues: 24.3 (+78.7%); Product Sales: 9.5 (+17.3%). More news on: Aralez Pharmaceuticals Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more …
Aralez Pharmaceuticals beats by $0.03, beats on revenue
Aralez Pharmaceuticals (NASDAQ: ARLZ ): Q3 EPS of -$0.37 beats by $0.03 . More news on: Aralez Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more …
Aralez Pharmaceuticals Inc. (ARLZ)